Metcela Inc. | Revolutionizing the Way We Treat Heart Failure > NEWS > PRESS RELEASE > Metcela Secures $12.7 Million Series B Financing to Initiate Phase I Clinical Trial in Chronic Heart Failure for MTC001 Cell Therapy > Logo_White back 2021.01.04 Logo_White back | Metcela Inc. | Revolutionizing the Way We Treat Heart Failure